Prevalence, antibiograms, and transferable tet(O) plasmid of campylobacter jejuni and campylobacter coli isolated from raw chicken, pork, and human clinical cases in Korea

Journal of Food Protection

Volumn 73, Issue 8, 2010, Pages 1430-1437

  Kim, Jun Man ^a   Hong, Joonbae ^b   Bae, Wonki ^a,c   Koo, Cheong ^a   Kim, So Hyen ^a,d   Park, Yong Ho ^a  

^a Seoul National University   (South Korea)

^b Korea Consumer Agency   (South Korea)

^c Standard Diagnostics Inc   (South Korea)

^d Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN; TET O RESISTANCE PROTEIN, BACTERIA;

ANALYSIS; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL COUNT; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CHICKEN; DOSE RESPONSE; DRUG EFFECTS; FOOD CONTAMINATION; FOOD CONTROL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KOREA; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PLASMID; PREVALENCE; PRODUCT SAFETY; SWINE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CARRIER PROTEINS; CHICKENS; COLONY COUNT, MICROBIAL; CONSUMER PRODUCT SAFETY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FOOD CONTAMINATION; FOOD MICROBIOLOGY; HUMANS; KOREA; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PREVALENCE; SWINE; TETRACYCLINE RESISTANCE;

EID: 77955946417     PISSN: 0362028X     EISSN: None     Source Type: Journal    
DOI: 10.4315/0362-028X-73.8.1430     Document Type: Article

References (54)

1. Aarestrap, F. M., F. Eager, N. E. Jensen, M. Madsen, A. Meyling, and H. C. Wegener. 1998. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS-106:606-622.
2. Aarestrap, F. M., and J. Engberg. 2001. Antimicrobial resistance of thermophilic Campylobacter. Vet. Res. 32:311-321.
3. Aarestrup, F. M., E. M. Nielsen, M. Madsen, and J. Engberg. 1997. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicroh. Agents Chemother. 41:2244-2250.
4. Aquino, M. H., C. P. Carvalho, A. Tibana, and R. M. Franko. 1996. Campylobacter jejuni-coli methodology of isolation and possible interfering factors in primary culture. J. Food Prot. 59:429-432.
5. Bacon, D. J., R. A. Aim, D. H. Burr, L. Hu, D. J. Kopecko, C. P. Ewing, T. J. Trust, and P. Guerry. 2000. Involvement of a plasmid in virulence of Campylobacter jejuni 81-176. Infect. Immun. 68:4384-4390.
6. Balse, M. 1997. Epidemiologic and clinical features of Campylobacter jejuni infections. J. Infect. Dis. 176:103-105.
7. Binotto, E., C. J. Mclver, and G. S. Hawkins. 2000. Ciprofloxacin- resistant Campylobacter jejuni infections. Med. J. Aust. 172:244-245.
8. S. Bryan, F. L., and M. P. Doyle. 1995. Health risks and consequences of Salmonella and Campylobacter jejuni in raw poultry. J. Food Prot. 58:326-344.
9. Butt, T., R. Ahmand, M. Mahmood, and S. Zaidi. 2003. Ciprofloxacin treatment failure in typhoid fever case, Pakistan. Emerg. Infect. Pis. 9:1621-1622.
10. Bywater, R., H. Deluyker, E. Deroover, A. de Jong, H. Marion, M. McConville, T. Rowan, T. Shryock, D. Shuster, V. Thomas, M. Valle, and J. Walters. 2004. A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals. J. Antimicrob. Chemother. 50:744-754.
11. Cabrita, J., J. Rodrigues, F. Braganca, C. Morgado, I. Pires, and A. P. Goncalves. 1992. Prevalence, biotypes, plasmid profile and antimicrobial resistance of Campylobacter isolated from wild and domestic animals from northeast Portugal. J. Appl. Bacteriol. 73:279-285.
12. Chuma, T., K. Makino, K. Okamoto, and H. Yugi. 1997. Analysis of distribution of Campylobacter jejuni and Campylobacter coli in broilers by using restriction fragment length polymorphism of flagellin gene. J. Vet. Med. Sci. 59:1011-1015.
13. Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolate or fastidious bacteria. Approved guidelines M45-A. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Connel, S. R., C. A. Trieber, G. P. Dinos, E. Einfeldt, D. E. Taylor, and K. H. Nierhaus. 2003. Mechanism of Tet(O)-mediated tetracycline resistance. EMBO J. 22:945-953.
15. Endtz, H. P., G. J. Ruijs, B. van Klingeren, W. H. Jansen, T. van der Reyden, and R. P. Mouton. 1991. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother. 27:199-208.
16. Engberg, J., F. M. Aarestrup, D. E. Taylor, P. Gerner-Smidt, and I. Nachamkin. 2001. Quinolone and macrolide resistance in Campylo-bacter jejuni and C. coli:resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:24-34.
17. Engberg, J., S. L. On, C. S. Harrington, and P. Gerner-Smidt. 2000. Prevalence of Campylobacter, Acrobacter, Helicobacter, and Stttter-ella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. J. Clin. Microbiol. 38:286-291.
18. Gaudreau, C, and H. Gilbert. 1997. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J. Antimicroh. Chemother. 39:707-712.
19. Gaudreau, C, and H. Gilbert. 1998. Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. Antimicrob. Agents Chemother. 42:2106-2108.
20. Gaudreau, C, and H. Gilbert. 2003. Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montreal, Canada. Antimicrob. Agents Chemother. 47:2027-2029.
21. Gibreel, A., V. N. Kos, M. Keelan, C. A. Trieber, S. Levesque, S. Michaud, and D. E. Taylor. 2005. Macrolide resistance in Campylobacter jejuni and Campylobacter coli:molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49:2753-2759.
22. Gibreel, A., D. M. Tracz, L. Nonaka, T. M. Ngo, S. R. Connel, and D. E. Taylor. 2004. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrob. Agents Chemother. 48:3442-3450.
23. Gonzalez, I., K. A. Grant, P. T. Richardson, S. F. Park, and M. D. Collins. 1997. Specific identification of the enteropathogens Campylobacter jejuni and Campylobacter coli by using a PCRr test based on the ceuE gene encoding a putative virulence determinant. J. Clin. Microbiol. 35:759-763.
24. Gupta, A., J. M. Nelson, T. J. Barrett, R. V. Tauxe, S. P. Rossiter, C. R. Friedman, K. W. Joyce, K. E. Smith, T. F. Jones, M. A. Hawkins, B. Shiferaw, J. L. Beebe, D. J. Vugia, T. Rabatsky-Ehr, J. A. Benson, T. P. Root, and F. J. Angulo. 2004. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg. Infect. Dis. 10:1102-1109.
25. Hart, W., M. Heuzenroeder, and M. Barton. 2004. Antimicrobial resistance in Campylobacter spp., Escherichia coli and enterococci associated with pigs in Australia. Aust. J. Vet. Med. Sci. 51:216-221.
26. Hong, J., J. M. Kim, W. K. Jung, S. H. Kim, W. Bae, H. C. Koo, J. Gil, M. Kim, J. Ser, and Y. H. Park. 2007. Prevalence and antibiotic resistance of Campylobacter spp. isolated from chicken meat, pork, and beef in Korea, from 2001 to 2006. J. Food Prot. 70:860-866.
27. Hudson, J., C. Nicol, J. Wright, R. Whyte, and S. K. Hassel. 1999. Seasonal variation of Campylobacter types from human cases, veterinary cases, raw chicken, milk and water. J.Appl Microbiol. 87:115-124.
28. Ketley, J. 1995. Virulence of Campylobacter spp.:a molecular genetic approach. J. Med. Microbiol. 42:312-327.
29. Korean Food and Drug Administration. 2005. Report on national antimicrobial resistance control. Korean Food and Drug Administration, Seoul.
30. Lee, C. Y., C. L. Tai, and S. C. Lin. 1994. Occurrence of plasmids and tetracycline resistance among Campylobacter jejuni and Campylobacter coli isolated from whole market chickens and clinical samples. Int. J. Food Microbiol. 24:161-170.
31. Li, C. C, C. H. Chiu, J. L. Wu, Y. C. Huang, and T. Y. Lin. 1998. Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan. Scand. J. Infect. Pis. 30:39-42.
32. McDermott, P. F., S. M. Bodeis, F. M. Aarestrup, S. Brown, M. Traczewski, P. Fedorka-Cray, M. Wallace, T. A. Critchley, C. Thomsberry, S. Graff, R. Flamm, J. Beyer, D. Shortridge, L. J. Piddock, V. Ricci, M. M. Johnson, R. N. Jones, B. Reller, S. Mirrett, J. Aldrobi, R. Rennie, C. Brosnikoff, L. Turnbull, G. Stein, S. Schooley, R. A. Hanson, and R. D. Walker. 2004. Development of a standardized susceptibility test for Campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, genta-micin and meropenem. Micrqb.DrugResist. 10:124-131.
33. Nachamkin, I. 1994. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to ciprofloxacin, erythromycin and tetracycline from 1982 to 1992. Med. Microbiol. Lett. 3:300-305.
34. Padungton, P., and J. B. Kaneene. 2003. Campylobacter spp. in human, chickens, pigs and their antimicrobial resistance. J. Vet. Med. Sci. 65:161-170.
35. Park, R. W. A., P. L. Griffiths, and G. S. Moreno. 1991. Sources and survival of Campylobacters:relevance to enteritis and food industry. J. Appl. Bacterial. 81:425-432.
36. Piddock, L. J., V. Ricci, K. Stanley, and K, Jones. 2000. Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK. .J. Antimicrob. Chemother. 46:303-306.
37. Pigrau, C., R. Bartolome, B. Almirante, A. M. Planes, J. Gavalda, and A. Pahissa. 1997. Bacteremia due to Campylobacter species:clinical findings and antimicrobial susceptibility patterns. Clin. Infect. Dis. 25:1414-1420.
38. Prasad, K. N., S. K. Mathur, T. N. Dhole, and A. Ayyagari. 1994. Antimicrobial susceptibility and plasmid analysis of Campylobacter jejuni isolated from diarrhoeal patients and healthy chickens in northern Tndia. J. Diarrhoeal Dis. Res. 12:270-273.
39. Pratt, S., and V. Korolik. 2005. Tetracycline resistance of Australian Campylobacter jejuni and Campylobacter coli isolates. J. Antimicrob. Chemother. 55:452-460.
40. Rautelin, H., O. V. Renkonen, and T. U. Kosunen. 1991. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob, 35:2065-2069.
41. Reina, J., M. J. Ros, and A. Serra. 1994. Susceptibilities to 10 antimicrobial agents of 1220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob. Agents Chemother. 38:2917-2920.
42. Saenz, Y., M. Zarazaga, M. Lantero, M. J. Gastanares, F. Baquero, and C. Torres. 2000. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain 1997-1998. Antimicrob. Agents Chemother. 44:267-271.
43. Sagara, H., A. Mochizuki, N. Okamura, and R. Nakaya. 1987. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob. Agents Chemother. 31:713-719.
44. Sanders, J. W., D. W. Isenbarger, S. E. Walz, L. W. Pang, D. A. Scott, C. Tamminga, B. A. Oyofo, W. C. Hewitson, J. L. Sanchez, C. Pitarangsi, P. Echeverria, and D. R. Tribble. 2002. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand:presentation and outcome of Campylobacter infection. Am. J. Trap. Med. Hyg. 67:533-538.
45. Schoeni, J. L., and M. P. Doyle. 1992. Reduction of Campylobacter jejuni colonization of chicks by cecum-colonizing bacteria producing anti-C. jejuni metabolites. Appl. Environ. Microbiol. 58:664-670.
46. Sjogren, E., B. Kaijser, and M. Werner. 1992. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden:a 10-year follow-up report. Antimicrob. Agents Chemother. 36:2847-2849.
47. Skirrow, M. B., and M. J. Blaser. 2000. Clinical aspects of Campylobacter infection, p. 69-88. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter, 2nd ed. American Society for Microbiology, Washington, DC.
48. Taylor, D. E., and A. Chau. 1996. Tetracycline resistance mediated by ribosomal protection. Antimicrob. Agents Chemother. 40:1-5
49. Taylor, D. E., and P. Courvalin. 1988. Mechanisms of antibiotic resistance in Campylobacter spp. Antimicrob. Agents Chemother. 32:1107-1112.
50. Taylor, D. E., S. A. De Grandis, M. A. Karmali, and P. C. Fleming. 1981. Transmissible plasmids from Campylobacter jejuni. Antimicrob. Agents Chemother. 19:831-835.
51. Taylor, D. N. and M. J. Blaser. 1991. Campylobacter infections, p. 151-172. In A. S. Evans and P. S. Brachman (ed.), Bacterial infections in humans, 2nd ed. Plenum Publishing, New York.
52. Tenover, F. C, S. Williams, K. P. Gordon, C. Nolan, and J. J. Plorde. 1985. Survey of plasmids and resistance factors in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 27:37-41.
53. Trieber, C. A., N. Burkhardt, K. H. Nierhaus, and D. E. Taylor. 1988. Ribosomal protection from tetracycline mediated by Tet(O):Tet(O) interaction with ribosomes is GTP-dependent. Biol. Chem. 379:847-855.
54. Velazquez, J. B., A. Jimenez, B. Chomon, and T. G. Villa. 1995. Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. J. Antimicrob. Chemother. 35:173-178.